{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Citing a lack of federal oversight of the dietary supplement industry, a state task force is recommending that New York provide its own supervision in order to give consumers basic information and protect them from dangerous products. While not seeking a ban on any specific supplements, the New York State Task Force on Life and the Law is calling for the creation of an expert committee, under the authority of the State Health Department, to evaluate the safety and efficacy of the supplements on the market.", "headline": {"main": "Role Urged For Albany In Policing Dietary Aids"}, "abstract": null, "print_page": "1", "word_count": 952, "_id": "4fd251078eb7c8105d7f4c9f", "snippet": "A state task force is recommending that New York provide its own supervision in order to give consumers basic information and protect them from dangerous products.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/10/06/nyregion/06health.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "HEALTH DEPARTMENT"}, {"name": "organizations", "value": "NEW YORK STATE TASK FORCE ON LIFE AND THE LAW"}, {"name": "subject", "value": "DIETARY SUPPLEMENTS AND HERBAL REMEDIES"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Marc", "rank": 1, "lastname": "SANTORA"}], "original": "By MARC SANTORA"}, "document_type": "article", "pub_date": "2005-10-06T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "In the late 1800's a New York surgeon named William B. Coley noticed that when one of his cancer patients developed a severe bacterial infection, the cancer disappeared. Over the following decades, Dr. Coley began injecting tumors with bacteria, with some success. But the results were inconsistent, and critics derided the work as quackery. ''Coley's toxins,'' as they were called, faded into disuse with the advent of radiation treatments and chemotherapy.", "headline": {"main": "A Revival For Immunity; Biotech Looks Anew at Old Ideas On Using the Body's Own Defenses"}, "abstract": "Drug companies are creating drugs to treat cancer, hepatitis and other diseases by activating toll-like receptors, class of human proteins that act as molecular sentinels, recognizing presence of bacteria or viruses and rousing rest of immune system to respond; other companies seek ways to suppress toll-like receptors in order to dampen immune system in patients with autoimmune conditions; one company active in research, Coley Pharmaceutical Group, is named in honor of Dr William B Coley, who in late 1880's sought with some success to treat cancer by injecting tumors with bacteria; table shows focus and status of toll-like receptor research at Anadys Pharmaceuticals, Coley, Dynavax Technologies, Idera Pharmaceuticals and SciClone Pharmaceuticals; photo of Dr Coley treating patient (M)", "print_page": "1", "word_count": 1732, "_id": "4fd24e1c8eb7c8105d7ef0a9", "snippet": "In the late 1800's a New York surgeon named William B. Coley noticed that when one of his cancer patients developed a severe bacterial infection, the cancer disappeared. Over the following decades, Dr. Coley began injecting tumors with bacteria, with...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9E0CE5D81130F936A35753C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "COLEY, WILLIAM B"}, {"name": "organizations", "value": "IDERA PHARMACEUTICALS"}, {"name": "organizations", "value": "DYNAVAX TECHNOLOGIES"}, {"name": "organizations", "value": "ANADYS PHARMACEUTICALS"}, {"name": "organizations", "value": "SCICLONE PHARMACEUTICALS"}, {"name": "organizations", "value": "COLEY PHARMACEUTICALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "TOLL-LIKE RECEPTORS"}, {"name": "subject", "value": "HEPATITIS"}, {"name": "subject", "value": "BACTERIA"}, {"name": "subject", "value": "IMMUNE SYSTEM"}, {"name": "subject", "value": "VIRUSES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2005-10-05T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Circuits", "lead_paragraph": "TO glimpse the real effect of today's computer networks, it helps to travel far beyond the high-tech hothouse of Silicon Valley, away from the venture capitalists, inventors and billionaire-wannabe entrepreneurs. To go where Google is just a search engine, not an obsession. Try Elkhart, Ind., home to Nibco Inc., a century-old maker and distributor of plumbing supplies. A private company, Nibco employs 3,000 workers and generates $500 million a year in sales. It faces stiff competition from Chinese producers.", "headline": {"main": "Working Together, Wherever They Are", "kicker": "COLLABORATION"}, "abstract": null, "print_page": "1", "word_count": 1446, "_id": "4fd2a90a8eb7c8105d894311", "snippet": "Networked computing is allowing workers to more efficiently nurture new ideas, new products and new ways to digitally automate all sorts of tasks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://tech2.nytimes.com/2005/10/05/technology/techspecial/05lohr.html", "multimedia": [{"url": "images/2005/10/05/technology/05cov.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/10/05/technology/05cov.75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "subject", "value": "COMPUTER SOFTWARE"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Steve", "rank": 1, "lastname": "LOHR"}], "original": "By STEVE LOHR"}, "document_type": "article", "pub_date": "2005-10-05T00:00:00Z", "section_name": "Technology"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Brazil said on Tuesday that it was close to completing an agreement with Abbott Laboratories that would almost halve the price it pays for Kaletra, a drug used to treat AIDS patients. The pending agreement, which would lower the drug's price to 63 cents a pill from $1.17, comes after months of negotiations and stern warnings from Brazil that it would disregard Abbott's patent and make a generic version of Kaletra domestically if the company did not lower the price to a level it deemed affordable.", "headline": {"main": "Brazil Near Deal With Abbott For Price Cut on AIDS Drug"}, "abstract": "Brazil says it is close to completing agreement with Abbott Laboratories that would almost halve price it pays for Kaletra, Abbott's AIDS drug (S)", "print_page": "7", "word_count": 354, "_id": "4fd24cb48eb7c8105d7ecc75", "snippet": "Brazil said that it was close to completing an agreement with Abbott Laboratories that would almost halve the price it pays for Kaletra, a drug used to treat AIDS patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/10/05/business/worldbusiness/05abbott.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "BRAZIL"}, {"name": "organizations", "value": "ABBOTT LABORATORIES INC"}, {"name": "organizations", "value": "ABBOTT LABORATORIES"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "KALETRA (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Paulo", "rank": 1, "lastname": "PRADA"}], "original": "By PAULO PRADA"}, "document_type": "article", "pub_date": "2005-10-05T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Health officials have warned for years that a virulent bird flu could kill millions of people, but few in Washington have seemed alarmed. After a closed-door briefing last week, however, fear of an outbreak swept official Washington, which was still reeling from the poor response to Hurricane Katrina. The day after the briefing, led by Michael O. Leavitt, the secretary of Health and Human Services, and other senior government health officials, the Senate squeezed $3.9 billion for flu preparations into a Pentagon appropriations bill.", "headline": {"main": "Fear of Flu Outbreak Rattles Washington"}, "abstract": "Congressional leaders are rattled by fears of avian flu outbreak following closed-door briefing by Sec Michael O Leavitt; Senate squeezes $3.9 billion for flu preparations into Pentagon appropriations bill and Democrats will propose flu pandemic coordinator at White House and buy-back program for unused vaccines; 32 Democratic senators send Pres Bush letter expressing concern about lack of preparedness, especially in aftermath of Hurricane Katrina disaster; Bush himself uses news conference to say he takes issue seriously; Harry Reid and Republican leader Bill Frist comment; Leavitt calls for effective global surveillance, which he will push during Asia trip, and for US to set up own surveillance; government says millions of courses of drug treatments are being purchased (M)", "print_page": "23", "word_count": 956, "_id": "4fd2a90a8eb7c8105d894316", "snippet": "Health officials have warned for years that a virulent bird flu could kill millions of people, but few in Washington have seemed alarmed. After a closed-door briefing last week, however, fear of an outbreak swept official Washington, which was still...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9B05EEDA1130F936A35753C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "REID, HARRY"}, {"name": "persons", "value": "LEAVITT, MICHAEL O"}, {"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "FRIST, BILL"}, {"name": "glocations", "value": "MISSISSIPPI"}, {"name": "glocations", "value": "NEW ORLEANS (LA)"}, {"name": "glocations", "value": "FAR EAST, SOUTH AND SOUTHEAST ASIA AND PACIFIC AREAS"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "glocations", "value": "LOUISIANA"}, {"name": "organizations", "value": "HEALTH AND HUMAN SERVICES DEPARTMENT"}, {"name": "organizations", "value": "FEDERAL EMERGENCY MANAGEMENT AGENCY"}, {"name": "subject", "value": "INFLUENZA"}, {"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "AVIAN INFLUENZA"}, {"name": "subject", "value": "KATRINA (STORM)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "HURRICANES AND TROPICAL STORMS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2005-10-05T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Florence Henderson. Fred and Ethel Mertz. They're not likely to knock Paris Hilton or Brad and Angelina off the cover of People. But pop culture figures of a certain age, or from a certain era, are playing lead roles in a vast new marketing and advertising blitz.", "headline": {"main": "To Promote a New Drug Benefit, Marketers Are Using Some Old Scripts", "kicker": "ADVERTISING: THE ADVERTISING COLUMN"}, "abstract": "Marketing campaigns for new Medicare prescription drug benefits face significant challenges, including target audience--older people--that does not typically attract marketers' time and money and the very complexity of benefit packages themselves; television campaigns are therefore emphasizing the friendly and familiar, including computer-altered clips of Fred and Ethel Mertz from I Love Lucy show (Pacificare), Florence Henderson (Cigna Senior Care) and Willard Scott (UnitedHealth Group); photos (M)", "print_page": "1", "word_count": 1502, "_id": "4fd24e1c8eb7c8105d7ef07a", "snippet": "Pop culture figures of a certain age, or from a certain era, are playing lead roles in a vast new marketing and advertising blitz.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/10/03/business/03medicare.html", "multimedia": [{"url": "imagepages/2005/10/03/business/03medicare_CA1.ready.html", "rank": "1", "height": 325, "width": 250, "legacy": {"MultimediaPopupWidth1": "250", "MultimediaUrl1": "imagepages/2005/10/03/business/03medicare_CA1.ready.html", "MultimediaPopupHeight1": "325", "MultimediaType1": "Image"}, "type": "Image"}, {"url": "images/2005/10/03/business/fredandethel-thumb.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/10/03/business/fredandethel-thumb.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "I LOVE LUCY (TV PROGRAM)"}, {"name": "persons", "value": "HENDERSON, FLORENCE"}, {"name": "persons", "value": "SCOTT, WILLARD"}, {"name": "persons", "value": "VANCE, VIVIAN"}, {"name": "persons", "value": "FRAWLEY, WILLIAM"}, {"name": "persons", "value": "HILTON, PARIS"}, {"name": "organizations", "value": "PACIFICARE HEALTH SYSTEMS"}, {"name": "organizations", "value": "CIGNA CORP"}, {"name": "organizations", "value": "UNITEDHEALTH GROUP"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "TELEVISION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Milt", "rank": 1, "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2005-10-03T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 6, "offset": 0, "time": 59}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}